# Efficacy and Safety of Prescription Omega-3 Fatty Acid Added to Stable Statin Therapy in Patients With Type 2 Diabetes and Hypertriglyceridemia

> **NCT02305355** · PHASE4 · COMPLETED · sponsor: **Kuhnil Pharmaceutical Co., Ltd.** · enrollment: 68 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2
- Hypertriglycemia

## Interventions

- **DRUG:** Omega-3-acids ethylesters 90 4g
- **DRUG:** Pravastatin, Simvastatin, Atorvastatin, Rosuvastatin

## Key facts

- **NCT ID:** NCT02305355
- **Lead sponsor:** Kuhnil Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2014-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02305355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02305355, "Efficacy and Safety of Prescription Omega-3 Fatty Acid Added to Stable Statin Therapy in Patients With Type 2 Diabetes and Hypertriglyceridemia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02305355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*